+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Australia & New Zealand Healthcare CROs Market Forecast to 2033- Product Image
Australia & New Zealand Healthcare CROs Market Forecast to 2033- Product Image
New

Australia & New Zealand Healthcare CROs Market Forecast to 2033

  • PDF Icon

    Report

  • 120 Pages
  • October 2025
  • Region: Australia, New Zealand
  • Grand View Research
  • ID: 5748336
REQUEST CUSTOMIZATION
Description Jump to:
The Australia & New Zealand healthcare CROs market size was estimated at USD 1.33 billion in 2024 and is projected to reach USD 3.35 billion by 2033, growing at a CAGR of 11.02% from 2025 to 2033. Supportive regulatory and ethical frameworks, government incentives and investment in R&D and advanced infrastructure and diverse patient pool are some of the key factors driving market growth.

The regulatory frameworks is anticipated to drive the clinical research activities in the Australia and New Zealand market. For instance, in New Zealand, it takes approximately 6.5 weeks to obtain regulatory approval and about 5 weeks for ethics approval. In Australia, the average time for regulatory approval is around 1 week, while ethics approval typically takes about 8 weeks, indicating the efficient yet different timelines for clinical trial governance in both nations. Swift ethics approval processes, standardized trial protocols, and well-recognized organizations such as the Therapeutic Goods Administration (TGA) and Medsafe help minimize start-up delays and improve adherence to ICH-GCP standards. This clear regulatory environment draws in global biopharmaceutical and medical device firms that are in search of consistent, high-quality research settings.

In addition, New Zealand has become a preferred destination for early-phase and adaptive clinical trials due to its rapid regulatory timelines, high-quality data standards, and cost-efficient trial execution. As a result, these regions have become preferred destinations for early-phase and adaptive clinical trials. This supportive framework lowers development costs and strengthens partnerships between sponsors and CROs, thereby expanding the healthcare contract research organization outlook.

Australia & New Zealand Healthcare CROs Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the Australia & New Zealand healthcare CROs market report based on type, service, therapeutic area, and end-use.

Type Outlook (Revenue, USD Million, 2021-2033)

  • Drug Discovery
  • Pre-clinical
  • Clinical

Service Outlook (Revenue, USD Million, 2021-2033)

  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/ Assurance
  • Bio-statistics
  • Investigator Payments
  • Laboratory
  • Patient And Site Recruitment
  • Technology
  • Others

Therapeutic Area Outlook (Revenue, USD Million, 2021-2033)

  • Oncology
  • CNS Disorders
  • Infectious Diseases
  • Immunological Disorders
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Diabetes
  • Ophthalmology
  • Pain Management
  • Others

End-use Outlook (Revenue, USD Million, 2021-2033)

  • Pharmaceutical
  • Medical Device

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Report Deliverables

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Service
1.2.3. Therapeutic Area
1.2.4. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Botton-Up Approach
1.7.4. Multivariate Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Australia & New Zealand Healthcare CROs Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Supportive Regulatory and Ethical Frameworks
3.2.1.2. Government Incentives and Investment in R&D and Advanced Infrastructure
3.2.1.3. Diverse Patient Pool
3.2.1.4. Cost-Effectiveness & Favorable Environment for Clinical Trials
3.2.2. Market Restraint Analysis
3.2.2.1. Quality Concerns in CRO Services
3.2.2.2. Intellectual Property Rights Issues
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Value Chain Analysis
3.6.1. Supply Trends
3.6.2. Demand Trends
3.7. Market Analysis Tools
3.7.1. Porter’s Five Force Analysis
3.7.2. PESTEL by SWOT Analysis
Chapter 4. Australia & New Zealand Healthcare CROs Market: Type Estimates & Trend Analysis
4.1. Australia & New Zealand Healthcare CROs Market, by Type: Segment Dashboard
4.2. Australia & New Zealand Healthcare CROs Market, by Type: Movement Analysis
4.3. Australia & New Zealand Healthcare CROs Market Estimates & Forecasts, by Type, 2021-2033 (USD Million)
4.4. Drug Discovery
4.4.1. Drug Discovery Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2. Target Validation
4.4.2.1. Target Validation Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3. Lead Identification
4.4.3.1. Lead Identification Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.4. Lead Optimization
4.4.4.1. Lead Optimization Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Pre-Clinical
4.5.1. Pre-Clinical Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Clinical
4.6.1. Clinical Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6.2. Phase I Trial Services
4.6.2.1. Phase I Trial Services Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6.3. Phase II Trial Services
4.6.3.1. Phase II Trial Services Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6.4. Phase III Trial Services
4.6.4.1. Phase III Trial Services Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6.5. Phase IV Trial Services
4.6.5.1. Phase IV Trial Services Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Australia & New Zealand Healthcare CROs Market: Service Estimates & Trend Analysis
5.1. Australia & New Zealand Healthcare CROs Market, by Service: Segment Dashboard
5.2. Australia & New Zealand Healthcare CROs Market, by Service: Movement Analysis
5.3. Australia & New Zealand Healthcare CROs Market Estimates & Forecasts, by Service, 2021-2033 (USD Million)
5.4. Project Management/Clinical Supply Management
5.4.1. Project Management/Clinical Supply Management Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Data Management
5.5.1. Data Management Market Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Regulatory/Medical Affairs
5.6.1. Regulatory/Medical Affairs Market Estimates and Forecasts, 2021-2033 (USD Million)
5.7. Medical Writing
5.7.1. Medical Writing Market Estimates and Forecasts, 2021-2033 (USD Million)
5.8. Clinical Monitoring
5.8.1. Clinical Monitoring Market Estimates and Forecasts, 2021-2033 (USD Million)
5.9. Quality Management/ Assurance
5.9.1. Quality Management/ Assurance Market Estimates and Forecasts, 2021-2033 (USD Million)
5.10. Bio-statistics
5.10.1. Bio-statistics Market Estimates and Forecasts, 2021-2033 (USD Million)
5.11. Investigator Payments
5.11.1. Investigator Payments Market Estimates and Forecasts, 2021-2033 (USD Million)
5.12. Laboratory
5.12.1. Laboratory Market Estimates and Forecasts, 2021-2033 (USD Million)
5.12.2. Sterility Testing
5.12.2.1. Sterility Testing Market Estimates and Forecasts, 2021-2033 (USD Million)
5.12.3. Container/Closure Testing
5.12.3.1. Container/Closure Testing Market Estimates and Forecasts, 2021-2033 (USD Million)
5.12.4. Extractables and Leachable Testing
5.12.4.1. Extractables and Leachable Testing Market Estimates and Forecasts, 2021-2033 (USD Million)
5.12.5. Environmental Monitoring (Including Microbiology Testing)
5.12.5.1. Environmental Monitoring (Including Microbiology Testing) Market Estimates and Forecasts, 2021-2033 (USD Million)
5.12.6. Disinfectant Efficacy Studies
5.12.6.1. Disinfectant Efficacy Studies Market Estimates and Forecasts, 2021-2033 (USD Million)
5.12.7. Others
5.12.7.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
5.13. Patient and Site Recruitment
5.13.1. Patient and Site Recruitment Market Estimates and Forecasts, 2021-2033 (USD Million)
5.14. Technology
5.14.1. Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
5.15. Others
5.15.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Australia & New Zealand Healthcare CROs Market: Therapeutic Area Estimates & Trend Analysis
6.1. Australia & New Zealand Healthcare CROs Market, by Therapeutic Area: Segment Dashboard
6.2. Australia & New Zealand Healthcare CROs Market, by Therapeutic Area: Movement Analysis
6.3. Australia & New Zealand Healthcare CROs Market Estimates & Forecasts, by Therapeutic Area, 2021-2033 (USD Million)
6.4. Oncology
6.4.1. Oncology Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. CNS Disorders
6.5.1. CNS Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Infectious Diseases
6.6.1. Infectious Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7. Immunological Disorders
6.7.1. Immunological Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8. Cardiovascular Diseases
6.8.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
6.9. Respiratory Diseases
6.9.1. Respiratory Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
6.10. Diabetes
6.10.1. Diabetes Market Estimates and Forecasts, 2021-2033 (USD Million)
6.11. Ophthalmology
6.11.1. Ophthalmology Market Estimates and Forecasts, 2021-2033 (USD Million)
6.12. Pain Management
6.12.1. Pain Management Market Estimates and Forecasts, 2021-2033 (USD Million)
6.13. Others
6.13.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Australia & New Zealand Healthcare CROs Market: End Use Estimates & Trend Analysis
7.1. Australia & New Zealand Healthcare CROs Market, by End Use: Segment Dashboard
7.2. Australia & New Zealand Healthcare CROs Market, by End Use: Movement Analysis
7.3. Australia & New Zealand Healthcare CROs Market Estimates & Forecasts, by End Use, 2021-2033 (USD Million)
7.4. Pharmaceutical Companies
7.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.2. Small Molecules
7.4.2.1. Small Molecules Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.3. Biologics
7.4.3.1. Biologics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Medical Device Companies
7.5.1. Medical Device Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Key Participant Categorization
8.1.1. Market Leaders
8.1.2. Emerging Players
8.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
8.3. Company Profiles
8.3.1. Paraxel International Corporation
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. SGS SA
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. ICON plc
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Thermo Fisher Scientific Inc.
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Medpace Australia Pty. Ltd
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Service Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Charles River Laboratories International, Inc.
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. IQVIA
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Novotech
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Service Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Laboratory Corporation of America Holdings
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Syneos Health
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Service Benchmarking
8.3.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Australia & New Zealand Healthcare CROs Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 4 Australia & New Zealand Healthcare CROs Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 5 Australia & New Zealand Healthcare CROs Market Estimates and Forecasts, by Therapeutic Area, 2021-2033 (USD Million)
Table 6 Australia & New Zealand Healthcare CROs Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2024 (USD Billion)
Figure 15 Ancillary market outlook, 2024 (USD Billion)
Figure 16 Australia & New Zealand Healthcare CROs Market Dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Australia & New Zealand Healthcare CROs Market: Type outlook and key takeaways
Figure 20 Australia & New Zealand Healthcare CROs Market: Type movement analysis
Figure 21 Drug Discovery Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 22 Target Validation Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 23 Lead Identification Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 24 Lead Optimization Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 25 Pre-Clinical Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 26 Clinical Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 27 Phase I Trial Services Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 28 Phase II Trial Services Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 29 Phase III Trial Services Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 30 Phase IV Trial Services Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 31 Australia & New Zealand Healthcare CROs Market: Service outlook and key takeaways
Figure 32 Australia & New Zealand Healthcare CROs Market: Service movement analysis
Figure 33 Project Management/Clinical Supply Management Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 34 Data Management Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 35 Regulatory/Medical Affairs Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 36 Medical Writing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 37 Clinical Monitoring Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 38 Quality Management/ Assurance Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 39 Bio-statistics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 40 Investigator Payments Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 41 Laboratory Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 42 Sterility Testing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 43 Container/Closure Testing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 44 Extractables and Leachable Testing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 45 Environmental Monitoring (Including Microbiology Testing) Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 46 Disinfectant Efficacy Studies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 47 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 48 Patient and site Recruitment Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 49 Technology Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 50 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 51 Australia & New Zealand Healthcare CROs Market: Therapeutic Area outlook and key takeaways
Figure 52 Australia & New Zealand Healthcare CROs Market: Therapeutic Area movement analysis
Figure 53 Oncology Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 54 CNS Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 55 Infectious Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 56 Immunological Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 57 Cardiovascular Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 58 Respiratory Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 59 Diabetes Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 60 Ophthalmology Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 61 Pain Management Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 62 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 63 Australia & New Zealand Healthcare CROs Market: End Use outlook and key takeaways
Figure 64 Australia & New Zealand Healthcare CROs Market: End Use movement analysis
Figure 65 Pharmaceutical Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 66 Small Molecules Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 67 Biologics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 68 Medical Device Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 69 Key company categorization
Figure 70 Service heat map analysis
Figure 71 Strategic framework

Companies Mentioned

The companies profiled in this Australia & New Zealand Healthcare CROs market report include:
  • PAREXEL International Corporation
  • Thermo Fischer Scientific, Inc.
  • SGS SA
  • ICON plc
  • Medpace Australia Pty. Ltd
  • Charles River Laboratories International, Inc.
  • IQVIA
  • Novotech
  • Laboratory Corporation of America Holdings
  • Syneos Health

Table Information

Report AttributeDetails
No. of Pages120
PublishedOctober 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 1.33 Billion
Forecasted Market Value ( USD ) by 2033 $ 3.35 Billion
Compound Annual Growth Rate11.0%
Regions CoveredAustralia, New Zealand
No. of Companies Mentioned11

Related Topics

Related Reports

Remote Healthcare Market - Global Strategic Business Report - Product Image

Remote Healthcare Market - Global Strategic Business Report

  • Report
  • 212 Pages
  • Global
From
Healthcare Contract Research Organization Market Forecast to 2033 - Product Image

Healthcare Contract Research Organization Market Forecast to 2033

  • Report
  • 120 Pages
  • Global
From
Healthcare Technology Management Market Size, Share & Trends Analysis Report by Technology Stack (Services, Software, Hardware, AI & Analytics), Deployment Mode (on-premise, Cloud-based), Functionality, End-use, Region, and Segment, 2025-2033 - Product Image

Healthcare Technology Management Market Size, Share & Trends Analysis Report by Technology Stack (Services, Software, Hardware, AI & Analytics), Deployment Mode (on-premise, Cloud-based), Functionality, End-use, Region, and Segment, 2025-2033

  • Report
  • 190 Pages
  • Global
From
Australia and New Zealand Healthcare CROs Market Report and Forecast 2025-2034 - Product Image

Australia and New Zealand Healthcare CROs Market Report and Forecast 2025-2034

  • Report
  • 200 Pages
  • Australia, New Zealand Australia, New Zealand
From
Pharmacies and Healthcare Stores Market Report 2025 - Product Image

Pharmacies and Healthcare Stores Market Report 2025

  • Report
  • 300 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.